DACOPAFANT
UNII H1T03Z1G60

Substance Identification & Data

This profile provides standardized clinical and technical data for Dacopafant, uniquely identified by the FDA Unique Ingredient Identifier (UNII) H1T03Z1G60.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 125372-33-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

H1T03Z1G60

CAS Registry Number

125372-33-0

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

DACOPAFANT

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C12H11N3OS

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

ARFOASMERCHFBY-GFCCVEGCSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C73132

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

205955

Unique identification number in the NCBI database of chemical substances.

INN ID

6584

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

S1[C@@H](n2c(C1)c(cc2)C(=O)N)c3cnccc3

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Dacopafant. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.